Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,同时终止与Ocuvex Inc.的并购协议,并与Veru Inc.达成880万美元债务和解。
此次融资将为公司提供重要的资金支持,而终止与Ocuvex Inc.的合并协议以及与Veru Inc.达成的债务和解协议,将有助于公司重新调整战略方向,专注于核心业务发展。
Onconetix Inc.宣布通过1290万美元D轮优先股和认股权证私募配售完成融资,同时终止与Ocuvex Inc.的并购协议,并与Veru Inc.达成880万美元债务和解。
此次融资将为公司提供重要的资金支持,而终止与Ocuvex Inc.的合并协议以及与Veru Inc.达成的债务和解协议,将有助于公司重新调整战略方向,专注于核心业务发展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.